Sala Michiel, Kroft Lucia J M, Röell Boudewijn, van der Grond Jeroen, Slagboom P Eline, Mooijaart Simon P, de Roos Albert, van Heemst Diana
Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands.
Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands; Netherlands Consortium for Healthy Ageing, Leiden, the Netherlands.
PLoS One. 2014 Mar 14;9(3):e91085. doi: 10.1371/journal.pone.0091085. eCollection 2014.
Familial longevity is marked by enhanced peripheral but not hepatic insulin sensitivity. The liver has a critical role in the pathogenesis of hepatic insulin resistance. Therefore we hypothesized that the extent of liver steatosis would be similar between offspring of long-lived siblings and control subjects. To test our hypothesis, we investigated the extent of liver steatosis in non-diabetic offspring of long-lived siblings and age-matched controls by measuring liver enzymes in plasma and liver fat by computed tomography (CT).
We measured nonfasting alanine transaminase (ALT), aspartate aminotransferase (AST), and Υ-glutamyl transferase (GGT) in 1625 subjects (736 men, mean age 59.1 years) from the Leiden Longevity Study, comprising offspring of long-lived siblings and partners thereof. In a random subgroup, fasting serum samples (n = 230) were evaluated and CT was performed (n = 268) for assessment of liver-spleen (L/S) ratio and the prevalence of moderate-to-severe non-alcoholic fatty liver disease (NAFLD). Linear mixed model analysis was performed adjusting for age, gender, body mass index, smoking, use of alcohol and hepatotoxic medication, and correlation of sibling relationship.
Offspring of long-lived siblings had higher nonfasting ALT levels as compared to control subjects (24.3 mmol/L versus 23.2 mmol/L, p = 0.03), while AST and GGT levels were similar between the two groups. All fasting liver enzyme levels were similar between the two groups. CT L/S ratio and prevalence of moderate-to-severe NAFLD was similar between groups (1.12 vs 1.14, p = 0.25 and 8% versus 8%, p = 0.91, respectively).
Except for nonfasting levels of ALT, which were slightly higher in the offspring of long-lived siblings compared to controls, no differences were found between groups in the extent of liver steatosis, as assessed with liver biochemical tests and CT. Thus, our data indicate that the extent of liver steatosis is similar between offspring of long-lived siblings and control subjects.
家族性长寿的特征是外周胰岛素敏感性增强,但肝脏胰岛素敏感性未增强。肝脏在肝胰岛素抵抗的发病机制中起关键作用。因此,我们假设长寿同胞的后代与对照受试者之间的肝脏脂肪变性程度相似。为了验证我们的假设,我们通过测量血浆中的肝酶以及利用计算机断层扫描(CT)测量肝脏脂肪,来研究长寿同胞的非糖尿病后代和年龄匹配的对照者的肝脏脂肪变性程度。
我们在来自莱顿长寿研究的1625名受试者(736名男性,平均年龄59.1岁)中测量了非空腹丙氨酸转氨酶(ALT)、天冬氨酸转氨酶(AST)和γ-谷氨酰转移酶(GGT),这些受试者包括长寿同胞的后代及其配偶。在一个随机子组中,对空腹血清样本(n = 230)进行了评估,并进行了CT检查(n = 268)以评估肝脾(L/S)比值和中重度非酒精性脂肪性肝病(NAFLD)的患病率。进行线性混合模型分析,对年龄、性别、体重指数、吸烟、饮酒和使用肝毒性药物以及同胞关系的相关性进行了校正。
与对照受试者相比,长寿同胞的后代非空腹ALT水平更高(24.3 mmol/L对23.2 mmol/L,p = 0.03),而两组之间的AST和GGT水平相似。两组之间所有空腹肝酶水平相似。两组之间CT L/S比值和中重度NAFLD的患病率相似(分别为1.12对1.14,p = 0.25;8%对8%,p = 0.91)。
除了非空腹ALT水平在长寿同胞的后代中略高于对照组外,通过肝脏生化检查和CT评估,两组之间在肝脏脂肪变性程度上没有差异。因此,我们的数据表明,长寿同胞的后代与对照受试者之间肝脏脂肪变性程度相似。